A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process

Microvascular Research

Volumn 83, Issue 2, 2012, Pages 154-161

  Hosokawa, Kazuya ^a,b   Ohnishi, Tomoko ^b   Fukasawa, Masashi ^b   Kondo, Taro ^b   Sameshima, Hisayo ^b   Koide, Takehiko ^c   Tanaka, Kenichi A ^d   Maruyama, Ikuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Fujimori Kogyo CO   (Japan)

^c UNIVERSITY OF HYOGO   (Japan)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; AR C 66096; BERAPROST; COLLAGEN; HIRUDIN; OS 1; PURINERGIC P2Y RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTICOAGULATION; ARTICLE; BLOOD VESSEL OCCLUSION; CAPILLARY; DRUG EFFICACY; FLOW MEASUREMENT; MICROCHIP ANALYSIS; MICROSCOPY; PRESSURE MEASUREMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SHEAR RATE; THROMBOCYTE; THROMBOGENESIS;

ADENOSINE TRIPHOSPHATE; ADULT; ANTIBODIES, MONOCLONAL; AREA UNDER CURVE; ASPIRIN; BLOOD PLATELETS; BLOOD PRESSURE; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOPROSTENOL; EQUIPMENT DESIGN; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; LAB-ON-A-CHIP DEVICES; MALE; MICROCHIP ANALYTICAL PROCEDURES; MICROSCOPY, VIDEO; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; REGIONAL BLOOD FLOW; STRESS, MECHANICAL; THROMBOSIS; TIME FACTORS;

EID: 84856788709     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2011.11.007     Document Type: Article

References (23)

1. Benard S.A., et al. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation. Biochemistry 2008, 47:4674-4682.
2. Breet N.J., et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA 2010, 303:754-762.
3. Frelinger A.L., et al. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization. Circulation 2009, 120:2586-2596.
4. Fressinaud E., et al. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood 1998, 91:1325-1331.
5. Hanson S.R., Sakariassen K.S. Blood flow and antithrombotic drug effects. Am. Heart J. 1998, 135:S132-S145.
6. Harrison P. Assessment of platelet function in the laboratory. Hamostaseologie 2009, 29:25-31.
7. Homoncik M., et al. Systemic inflammation increases shear stress-induced platelet plug formation measured by the PFA-100. Br. J. Haematol. 2000, 111:1250-1252.
8. Kageyama S., et al. Effect of a humanized monoclonal antibody to von Willebrand factor in a canine model of coronary arterial thrombosis. Eur. J. Pharmacol. 2002, 443:143-149.
9. Kikura M., et al. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood. Platelets 2000, 11:446-458.
10. Kunapuli S.P. P2 receptors and platelet activation. Sci. World J. 2002, 2:424-433.
11. Kundu S.K., et al. Description of an in vitro platelet function analyzer-PFA-100. Semin. Thromb. Hemost. 1995, 21(Suppl. 2):106-112.
12. Mammen E.F., et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin. Thromb. Hemost. 1998, 24:195-202.
13. Maree A.O., Fitzgerald D.J. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation 2007, 115:2196-2207.
14. Mendolicchio G.L., et al. Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood. J. Thromb. Haemost. 2011, 9:373-382.
15. Michelson A.D. Methods for the measurement of platelet function. Am. J. Cardiol. 2009, 103:20A-26A.
16. Michelson A.D., et al. Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'. J. Thromb. Haemost. 2007, 5:75-81.
17. Nakagawa O., et al. Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system. Circulation 1994, 90:1643-1647.
18. Price M.J. Bedside evaluation of thienopyridine antiplatelet therapy. Circulation 2009, 119:2625-2632.
19. Raman S., Jilma B. Time lag in platelet function inhibition by clopidogrel in stroke patients as measured by PFA-100. J. Thromb. Haemost. 2004, 2:2278-2279.
20. Satoh K., et al. Small aggregates of platelets can be detected sensitively by a flow cytometer equipped with an imaging device: mechanisms of epinephrine-induced aggregation and antiplatelet effects of beraprost. Cytometry 2002, 48:194-201.
21. Savage B., et al. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996, 84:289-297.
22. Strony J., et al. Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis. Am. J. Physiol. 1993, 265:H1787-H1796.
23. Szlam F., et al. In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition. Thromb. Haemost. 2010, 103:863-865.